The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 30

More JCP Articles

JCP
Should Blind Psychiatrists Be Paid Less?
Commentary

May 23, 2022

Dr Zimmerman comments on a recent meta-analysis by Scott and colleagues on the use of video-based telehealth in treatment of PTSD.
Mark Zimmerman, MD
JCP
Telehealth vs Face-to-Face Management for PTSD in Primary Care
Meta-Analysis

May 23, 2022

This timely meta-analysis compared telehealth with face-to-face care for patients with PTSD, examining PTSD severity, QoL, therapeutic alliance, and other aspects.
Anna Mae Scott, Mina Bakhit, Hannah Greenwood, et al
JCP
Clozapine Use in Singapore and Hong Kong
Original Research

May 18, 2022

This survey investigated clinicians’ use of clozapine for schizophrenia, beliefs about its effectiveness, and concerns regarding this medication.
Shushan Zheng, Jimmy Lee, Sherry Kit Wa Chan
JCP
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
Insight videos

May 17, 2022

Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
Raymond W. Lam
JCP
Youth Aware of Mental Health (YAM) Intervention
Original Research

May 16, 2022

Youth Aware of Mental Health (YAM) is a manualized universal intervention designed to increase mental health awareness about protective factors, depression and suicide, and coping skills. This study assessed…
Madhukar H. Trivedi, Karabi Nandy, Taryn L. Mayes, et al
JCP
Eating Disorders in Youth With Bipolar Disorder
Original Research

May 11, 2022

Research has shown the importance of comorbid eating disorders (ED) in bipolar disorder (BD), though most studies have focused on adults. This study examined the prevalence and correlates of…
Diana Khoubaeva, Mikaela K. Dimick, Jessica L. Roane, et al
JCP
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ May 11, 2022

This post hoc analysis of phase 2 data evaluated rates and time course of response with the new combination oral agent KarXT (xanomeline−trospium) in the treatment of schizophrenia.
Peter J. Weiden, Alan Breier, Sarah Kavanagh, et al
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
Original Research

May 9, 2022

This study investigated whether dose is a factor in the development of metabolic side effects with atypical antipsychotics.
Marianna Piras, Céline Dubath, Mehdi Gholam, et al
JCP
Corrigendum to “Decreases in Suicidality Following Psychedelic Therapy: A Meta-Analysis of Individual Patient Data Across Clinical Trials”
Letter to the Editor

May 9, 2022

The authors note two suicidality-related events that occurred within the studies included in their recent meta-analysis.
Richard J. Zeifman, Dengdeng Yu, Nikhita Singhal, et al
JCP
A Practical Guide for Tailoring Treatment Choices in Interventional Psychiatry
ASCP Corner

May 4, 2022

When 2 or more antidepressant trials have failed in patients with MDD, what comes next? This article compares 3 next-step interventions—TMS, esketamine/ketamine, and ECT—with a focus on incorporating the…
Joshua Berman, Adrian Jacques Ambrose
JCP
Epilepsy and Suicide Attempt
Original Research

May 2, 2022

From a sample of 1,229 adults who attempted suicide, this study found an elevated frequency of epilepsy and identified clinical factors that might play a role.
Basma Akrout Brizard, Philippe Courtet, Isabelle Jaussent, et al
JCP
Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD
Original Research

April 27, 2022

This study investigated whether receiving antidepressants increases the chance that patients with opioid use disorder will remain on buprenorphine treatment.
Kun Zhang, Christopher M. Jones, Wilson M. Compton, et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe